Your browser doesn't support javascript.
loading
The NPM1 mutant defines AML irrespective of blast count.
Falini, Brunangelo; Martelli, Maria Paola; Brunetti, Lorenzo; Gjertsen, Bjorn T; Andresen, Vibeke.
Affiliation
  • Falini B; Institute of Hematology and Center for Hemato-Oncological research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Martelli MP; Institute of Hematology and Center for Hemato-Oncological research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Brunetti L; Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Gjertsen BT; Institute of Hematology, Azienda Ospedaliero-Universitarià delle Marche, Ancona, Italy.
  • Andresen V; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
Am J Hematol ; 98(7): E187-E189, 2023 07.
Article in En | MEDLINE | ID: mdl-37119006
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: Italy